HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GOP Senate Takeover Makes Bipartisanship Crucial For Cosmetics Bill

This article was originally published in The Rose Sheet

Executive Summary

With a new Republican majority in the Senate, legislation to overhaul cosmetics regulation in the U.S., which to date has been driven by Democrats, will need bipartisan support to advance. A draft bill is being developed by Sen. Dianne Feinstein, D-Calif., in collaboration with industry members and CEOs.

You may also be interested in...



Feinstein Bill To Mandate Fragrance Ingredient Contacts, Not Disclosure

Cosmetics legislation poised for introduction in the Senate is likely to uphold the trade-secret status of fragrance compositions, promoting “a direct communication line” between FDA and fragrance houses rather than requiring full disclosure of fragrance ingredients, according to IFRA North America.

Sen. Feinstein Plans Cosmetics Bill In Collaboration With Industry, NGOs

Prospects for the developing draft bill are optimistic given the California democratic senator’s reputation for working “effectively across the aisle” and her receptivity to both industry and NGO stakeholders. Janet Nudelman, co-founder of the Campaign for Safe Cosmetics, says the legislation will pick up where negotiations between FDA and industry left off earlier in 2014.

Industry/FDA Relations Will Benefit From Westine’s White House Experience

Incoming Personal Care Products Council President Lezlee Westine's experience in navigating the waters of Washington politics will be a major benefit in the Council's relationship with FDA, Estee Lauder Companies Vice Chairman and President Dan Brestle suggested
UsernamePublicRestriction

Register

RS019297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel